Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
SKLB-610 inhibited angiogenesis-related tyrosine kinase VEGFR2
2-hydroxyglutarate (2HG)
is a cell- and brain-permeable
Delvaeye T
Sephin1 was orally dosed to MPZmutant mice or SOD1mutant mice at 1 mg/Kg twice a day
Ledipasvir - CAS# 1256388-51-8 0153 SKLB-610 inhibited angiogenesis-related tyrosine kinaseLedipasvir, also known as GS 5885, CAS No. 1256388 51 8, is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg sofosbuvir 400 mg (trade name Harvoni). The ledipasvir sofosbuvir combination is a direct acting antiviral agent that interferes with HCV replication and can be used to treat
US$ 4370.98
US$ 448.88
US$ 7129.59
US$ 2546.99
US$ 275.69
US$ 1762.72
US$ 488.72
US$ 1163.24